Increasing the Thickness of Soft Tissues in the Esthetic Zone Around Implants

Comparative Analysis of the Effectiveness of Various Methods of Increasing the Thickness of Soft Tissues During Dental Implantation in the Esthetic Zone of the Maxilla

This is an interventional prospective randomized clinical trial (RCT) in parallel groups. This study is aimed at detecting a difference in the increase in the thickness of soft tissues of at least 0.3 mm between the two groups (the standard deviation [SD] of 0.3 mm and the average value of 1.2 mm was borrowed from an article published by Cairo F et al., 2017). Using SampleSizeCalculator, it was calculated that the number of patients in each group should be 14 (alpha = 0.05; power = 80%). This number was increased by 10%, taking into account possible exceptions from the study. The sample size is 30 patients who will be randomly divided into two groups depending on the surgical intervention used. First group - patients will undergo increasing the thickness of the mucous membrane using free connective tissue graft from tuberosity area of the maxilla or palate. Second group - patients will undergo increasing the thickness of the mucous membrane using collagen matrix "Fibro-Gide" (Geistlich Pharma AG, Bahnhofstrasse 40, 6110 Wolhusen, Switzerland; registration in Russia 19.08.2020 No FSZ-20207/11765). In the postoperative period the value of soft tissue thickness gain, severity of pain syndrome, collateral edema, Doppler flowmetry, probing depth, soft tissue aesthetics, keratinized mucosa width and quality of life will be assessed. In addition, after 3 months simultaneously with installation of gingiva formers biopsy specimens will be sampled with mucotome in the area of the intervention followed by histomorphometric analysis of the obtained biopsies.

Study Overview

• Status: Recruiting
• Conditions: Soft Tissue Atrophy
• Intervention / Treatment: Procedure: Soft tissue augmentation with CTG; Procedure: Soft tissue augmentation with CM

Detailed Description

The aim of this research is to perform a comparative clinical and histomorphometric analysis of soft tissues in the area of soft tissue graft and collagen matrix transplantation. Thirty patients diagnosed with partial absence of teeth will be examined on the basis of the Department of Surgical Dentistry of the E.V. Borovsky Institute of Dentistry of I.M. Sechenov First Moscow State Medical University. Patients have a soft tissue thickness deficiency from the vestibular surface in the area of the planned dental implant placement in the esthetic zone of the maxilla, which is an indication for its increase. All patients will be randomly divided into two groups depending on method of soft tissue augmentation used. In 1 group (n=15) transplantation of a free connective tissue graft (CTG) from tuberosity area of the maxilla or palate is performed. In 2 group (n=15) collagen matrix "Fibro-Gide" will be used. According to gender and age characteristics, both groups will be comparable. Randomization of patients will be carried out at the stage of surgical intervention as follows: after a dental implant placement and preparation of recipient's bed, an envelope with a randomly assigned treatment method (using a connective tissue graft or a collagen matrix) will be opened.

During the operation, incision will be made along the top of the alveolar ridge within the defect; a full-thickness muco-periosteal flap will be elevated. Traditional 2-stage dental implantation is performed according to surgical protocols of dental implant systems Astra Tech (Dentsply Implants Manufacturing GmbH, Germany; registration in Russia 27.12.2019 No FSZ 2015/3214). A free connective tissue graft will be harvested in patients of the first group. Graft will be fixed with a horizontal U-shaped suture to the buccal muco-periosteal flap. In second patients group a fragment of the collagen matrix "Fibro-Gide" will be fixed to the buccal muco-periosteal flap (Geistlich Pharma AG, Bahnhofstrasse 40, 6110 Wolhusen, Switzerland; registration in Russia 19.08.2020 No FSZ - 20207/11765). For patients of all groups mobilization of the muco-periosteal flap conducts followed by suturing the wound tightly without tension with simple interrupted sutures.

Postoperative recommendations will include rinsing with 0.2% chlorhexidine gluconate mouthwash solution (Corsodyl, GlaxoSmithKline 77.99.11.915.Д.005285.07.03) twice a day for a week and receiving antibiotic (Amoxicillin + Clavulanic Acid, 1 g Amoxiclav, LEK, d.d., Slovenia, 22.07.2011, П N012124/01) twice a day for 5 days. To relieve pain, 100 mg of Nimesulide (Nise; Dr. Reddy's Laboratories Ltd., India, 26.05.2009, П N012824/03) will be prescribed. The stage of the implant uncovering with hilling abutments installation is carried out 3 months after the intervention. At this stage, a soft tissue fragment will be taken using a mucotome in the area of the previously performed mucous membrane thickness increasing for subsequent histomorphometric analysis. In the study we will use both conventional light microscopy (microscopy in the light field) and polarizing microscopy - to estimate the content of collagen fibers in preparations stained with picrosirius red. During a morphometric study we will carry out a quantitative assessment of the characteristics of the epithelial layer, the basement membrane relative length (the ratio of the absolute length of the basement membrane to the length of the epithelial layer), the characteristics of the underlying connective tissue.

• Study Type: Interventional
• Enrollment (Anticipated): 30
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Igor Ashurko; Phone Number: +7-926-515-05-55; Email: ashurko_i_p@staff.sechenov.ru
• Study Contact Backup: Name: Daria Krylova; Phone Number: +7-916-017-24-70; Email: saveleva_d_a@student.sechenov.ru

Study Locations

• Russian Federation
  • Moscow, Russian Federation
    • Recruiting
    • I.M. Sechenov First Moscow State Medical University (Sechenov University)
    • Contact: Igor Ashurko; Phone Number: +7-926-515-05-55; Email: ashurko_i_p@staff.sechenov.ru
    • Contact: Daria Krylova; Phone Number: +7-916-017-24-70; Email: saveleva_d_a@student.sechenov.ru
    • Principal Investigator: Igor Ashurko
    • Sub-Investigator: Daria Krylova

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 16 years to 43 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. The presence of written informed consent of the patient to participate in the study;
2. Age from 18 to 45 years;
3. The presence of an included defect in the esthetic zone part of maxilla with a sufficient volume of bone tissue;
4. Soft tissue thickness <3 mm on the vestibular side;
5. Adjacent teeth without periodontal pathology, the depth of probing should not exceed 3 mm along the entire dentoalveolar furrow;
6. Satisfactory level of oral hygiene;
7. Patients without concomitant pathology or with concomitant pathology in the compensation stage.

Non-inclusion criteria:

1. Age less than 18 and more than 45 years;
2. Heavy smokers (more than 10 cigarettes a day);
3. Patients with somatic diseases in the stage of decompensation or in the stage of exacerbation;
4. Patients with malignant tumors, as well as patients with a history of radiation and chemotherapy over the past 5 years;
5. Taking medications that affect the healing of soft tissues (nonsteroidal anti-inflammatory drugs, steroid drugs);
6. Pregnancy and breastfeeding;
7. Patients with mental disorders.

Exclusion Criteria:

1. Patients with infections either periodontally or periapically, which developed after inclusion in the study;
2. Pregnancy following entrance into the study;
3. Patients having poor oral hygiene or not wanting to carry out oral hygiene measures;
4. Patients who, for one reason or another, could not complete the entire protocol to the end.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: First group; The patients undergo implant placement in combination with an increase in the thickness of soft tissues using a free connective tissue graft from the tuber region on the maxilla or palate.	Procedure: Soft tissue augmentation with CTG; Incision the mucosa at the alveolar ridge, mucosal-periosteal flap elevation; Placement of the Astra Tech dental implant (Dentsply, Germany); Sampling of free connective tissue graft from the maxilla tuber area; Fixation of the graft to the vestibular flap; Suturing the wound tightly
Experimental: Second group; The patients undergo implant placement in combination with an increase in the thickness of soft tissues using collagen matrix "Fibro-Gide"	Procedure: Soft tissue augmentation with CM; Incision the mucosa at the alveolar ridge, mucosal-periosteal flap elevation; Placement of the Astra Tech dental implant (Dentsply, Germany); Modeling of sterile collagen matrix according to the shape of the recipient bed; Fixation of the collagen matrix to the vestibular flap; Suturing the wound tightly

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The amount of soft tissue thickness gain	The value of the increase in the thickness of soft tissues in the study area (mm) on the 90th day compared to the 0th day (initial value).To carry out the measurement an optical impression will be taken using the Primescan intraoral scanner (Dentsply/SIRONA,Germany, 16.05.2019, № РД-27221/26851) before the operation and on the 90th day after the operation. Further, in the specialized program GOM Inspect the stl-files will be compared and the vestibular contour changes will be evaluated at 3 equidistant points in the coronary-apical direction.	Day 90 compared to the 0th day (initial value)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Assessment of the severity of pain syndrome	Visual Analogue Scale (VAS). Evaluation of the severity of pain syndrome is carried out after surgery using a questionnaire, where : 0 - absence of pain; 1-2 - weak pain; 3-4 - moderate pain; 5-6 - moderate-severe pain; 7-8 - severe pain; 9-10 - unbearable pain.	Day 1 compared to the 0th day (initial value)
Assessment of the severity of pain syndrome	Visual Analogue Scale (VAS). Evaluation of the severity of pain syndrome is carried out after surgery using a questionnaire, where : 0 - absence of pain; 1-2 - weak pain; 3-4 - moderate pain; 5-6 - moderate-severe pain; 7-8 - severe pain; 9-10 - unbearable pain.	Day 3 compared to the 0th day (initial value)
Assessment of the severity of pain syndrome	Visual Analogue Scale (VAS). Evaluation of the severity of pain syndrome is carried out after surgery using a questionnaire, where : 0 - absence of pain; 1-2 - weak pain; 3-4 - moderate pain; 5-6 - moderate-severe pain; 7-8 - severe pain; 9-10 - unbearable pain.	Day 5 compared to the 0th day (initial value)
Assessment of the collateral edema	Edema will be clinically assessed by its volume (scores 0-2; 0 points - no edema, 1 point - moderate edema, 2 points - intense edema compared to the condition of adjacent tissues).	Day 3 compared to the 0th day (initial value)
Assessment of the collateral edema	Edema will be clinically assessed by its volume (scores 0-2; 0 points - no edema, 1 point - moderate edema, 2 points - intense edema compared to the condition of adjacent tissues)	Day 5 compared to the 0th day (initial value)
Assessment of the collateral edema	Edema will be clinically assessed by its volume (scores 0-2; 0 points - no edema, 1 point - moderate edema, 2 points - intense edema compared to the condition of adjacent tissues).	Day 7 compared to the 0th day (initial value)
Assessment of the quality of life	The patient's quality of life will be assessed using the Oral Health Impact Profile-14 (OHIP-14) questionnaire.	Day 7 compared to the 0th day (initial value)
Assessment of the quality of life	The patient's quality of life will be assessed using the Oral Health Impact Profile-14 (OHIP-14) questionnaire.	Day 90-93 compared to the 0th day (initial value)
Assessment of the quality of life	The patient's quality of life will be assessed using the Oral Health Impact Profile-14 (OHIP-14) questionnaire.	Day 180-186 compared to the 0th day (initial value)
Doppler flowmetry	Doppler flowmetry will be carried out using the LAKK-02 apparatus (LLC Scientific and Production Enterprise "LAZMA" Russia) Registration certificate of the Ministry of Health of the Russian Federation No.29/03020703/5555-03 dated 11.09.2003).	Day 7 compared to the 0th day (initial value)
Doppler flowmetry	Doppler flowmetry will be carried out using the LAKK-02 apparatus (LLC Scientific and Production Enterprise "LAZMA" Russia) Registration certificate of the Ministry of Health of the Russian Federation No.29/03020703/5555-03 dated 11.09.2003).	Day 30-31 compared to the 0th day (initial value)
Doppler flowmetry	Doppler flowmetry will be carried out using the LAKK-02 apparatus (LLC Scientific and Production Enterprise "LAZMA" Russia) Registration certificate of the Ministry of Health of the Russian Federation No.29/03020703/5555-03 dated 11.09.2003).	Day 90-93 compared to the 0th day (initial value)
Doppler flowmetry	Doppler flowmetry will be carried out using the LAKK-02 apparatus (LLC Scientific and Production Enterprise "LAZMA" Russia) Registration certificate of the Ministry of Health of the Russian Federation No.29/03020703/5555-03 dated 11.09.2003).	Day 180-186 compared to the 0th day (initial value)
Histomorphometric analysis	Simultaneously with installation of gingiva formers, a soft tissue fragment is taken using a mucotome in the area of the previously performed mucous membrane thickness increasing for subsequent histomorphometric analysis. In the study, we use both conventional light microscopy (microscopy in the light field) and polarizing microscopy - to estimate the content of collagen fibers in preparations stained with picrosirius red. During a morphometric study, we carry out a quantitative assessment of the characteristics of the epithelial layer, the basement membrane relative length (the ratio of the absolute length of the basement membrane to the length of the epithelial layer), the characteristics of the underlying connective tissue.	Day 90-93 compared to the 0th day (initial value)
Soft tissue aesthetics	Evaluation of soft tissue aesthetics will be carried out by visual inspection taking into account the PES (pink aesthetic score).	Day 180-186 compared to the 0th day (initial value)
Keratinized mucosa width	Evaluation of the keratinized mucosa width will be carried out using a periodontal probe.	Day 180-186 compared to the 0th day (initial value)
Probing depth	The probing depth will be carried out using a periodontal probe in the medial and distal papillae	Day 180-186 compared to the 0th day (initial value)

Collaborators and Investigators

• Sponsor: I.M. Sechenov First Moscow State Medical University
• Investigators: Principal Investigator: Igor Ashurko, I.M. Sechenov First Moscow State Medical University (Sechenov University)

Study record dates

Study Major Dates

• Study Start (Actual): June 9, 2022
• Primary Completion (Anticipated): December 10, 2022
• Study Completion (Anticipated): April 15, 2023

Study Registration Dates

• First Submitted: September 20, 2022
• First Submitted That Met QC Criteria: September 22, 2022
• First Posted (Actual): September 23, 2022

Study Record Updates

• Last Update Posted (Actual): September 23, 2022
• Last Update Submitted That Met QC Criteria: September 22, 2022
• Last Verified: September 1, 2022

More Information

Terms related to this study

• Keywords: soft tissue augmentation; connective tissue graft; dental implant; xenogeic collagen matrix; increasing of soft tissue thickness
• Additional Relevant MeSH Terms: Pathological Conditions, Anatomical; Atrophy
• Other Study ID Numbers: 10012022

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No
• IPD Plan Description: IPD Sharing is impossible because of the recommendation of the local ethics committee, the provision of data is possible upon receipt of an official request addressed to the chief researcher.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No